Antimicrobial susceptibility of 128 Salmonella enterica serovar typhi and paratyphi A isolates from Northern India

Chemotherapy

Volumn 50, Issue 2, 2004, Pages 88-91

  Safdar, Amar ^a   Kaur, Harjit ^b   Elting, Linda ^a   Rolston, Kenneth V I ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Antimicrobial resistance; Salmonella paratyphi A; Salmonella typhi

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFOPERAZONE; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; PEFLOXACIN; SPARFLOXACIN; TETRACYCLINE; TRIMETHOPRIM;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOOD ANALYSIS; BLOOD SAMPLING; CHEMOPROPHYLAXIS; CHILD; CONTROLLED STUDY; FECES ANALYSIS; GRAM NEGATIVE BACTERIUM; GROUPS BY AGE; HUMAN; INDIA; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SEROTYPE; TYPHOID FEVER;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FECES; HOSPITALS, TEACHING; HUMANS; INDIA; INPATIENTS; PROSPECTIVE STUDIES; SALMONELLA INFECTIONS; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; SEROTYPING; SPECIES SPECIFICITY;

EID: 3042577484     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077808     Document Type: Article

References (24)

1. Osler W: The principles and practice of medicine: designed for the use of practitioners and students of medicine. ed 8. New York, Appleton, 1912, pp 1-46.
2. Ackers ML, Puhr ND, Tauxe RV, Mintz ED: Laboratory-based surveillance of Salmonella serotype typhi infections in the United States. Antimicrobial resistance on the rise. JAMA 2000;283:2668-2673.
3. Caumes E, Ehya N, Nguyen J, Bricaire F: Typhoid and paratyphoid fever: A 10-year retrospective study of 41 cases in a Parisian hospital. J Travel Med 2001;8:293-297.
4. Mirza SH, Beeching NJ, Hart CA: Multi-drug resistant typhoid: A global problem. J Med Microbiol 1996;44:317-319.
5. Parry CM, Tran T, Dougan G, White NJ, Farrar JJ: Medical progress: Typhoid fever. N Engl J Med 2002;347:1770-1782.
6. Centers for Disease Control and Prevention: Epidemic typhoid fever - Dushanbe, Tajikistan, 1997. MMWR Morb Mortal Wkly Rep 1998;47:752-756.
7. Centers for Disease Control and Prevention: Typhoid immunization. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1990;39(RR-10):1-5.
8. National Committee for Clinical Laboratory Standards: Performance Standards of Antimicrobial Disk Susceptibility Tests. Wayne, Pa: National Committee for Clinical Laboratory Standards; 2000. Publication M2A2.
9. Safdar A: Infectious diarrhea in the southeastern United States, 1998-2000. Clin Infect Dis 2003;36:533-534.
10. Dunne EF, Fey PD, Kludt P, et al: Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-Lactamase. JAMA 2000;284:3151-3156.
11. Launay O, Nguyen Van JC, Buu-Hoi A, Acar JF: Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones. Clin Microbiol Infect 1997;3:541-544.
12. Threlfall JE, Skinner JA, Ward LR: Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi and Paratyphi A. J Antimicrob Chemother 2001;48:735-748.
13. Mandal S, Mandal MD, Pal NK: Antimicrobial resistance pattern of Salmonella typhi isolates in Kolkata, India during 1991-2001: A retrospective study. Jpn J Infect Dis 2002;55:58-59.
14. Threlfall EJ, Ward LR, Rowe B, et al: Widespread occurrence of multiple drug-resistant Salmonella typhi in India. Eur J Clin Microbiol Infect Dis 1992;11:990-993.
15. Hermans PWM, Saha SK, van Leeuwen WJ, Verbrugh HA, van Belkum A, Goessens WHF: Molecular typing of Salmonella typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates. J Clin Microbiol 1996;34:1373-1379.
16. Hazir T, Qazi SA, Abbas KA, Khan MA: Therapeutic re-appraisal of multiple drug resistant Salmonella typhi (MDRST) in Pakistani children. J Pak Med Assoc 2002;52:123-127.
17. Shanahan PM, Karamat KA, Thomson CJ, Amyes SGB: Characterization of multi-drug resistant Salmonella typhi from Pakistan. Epidemiol Infect 2000;124:9-16.
18. Hoa NTT, Diep TS, Wain J, et al: Community-acquired septicaemia in southern Viet Nam: The importance of multidrug-resistant Salmonella typhi. Trans R Soc Trop Med Hyg 1998;92:503-508.
19. Kumar R, Aneja KR, Punia AK, Roy P, Sharma M, Gupta R, Ram S: Changing pattern of biotypes, phage types & drug resistance of Salmonella typhi in Ludhiana during 1980-1999. Indian J Med Res 2001;113:175-180.
20. Rahman M, Ahmad A, Shoma S: Decline in epidemic of multidrug resistant Salmonella typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002;129:29-34.
21. Chande C, Shrikhande S, Kapale S, Agrawal S, Fule RP: Change in antimicrobial resistance pattern of Salmonella typhi in central India. Indian J Med Res 2002;115:248-250.
22. Kidgell C, Pickard D, Wain J, et al: Characterization and distribution of a cryptic Salmonella typhi plasmid pHCM2. Plasmid 2002;47:159-171.
23. Rupali P, Abraham OC, Jesudason M, et al: Clinical and microbiological failure of ciprofloxacin (CIP) in typhoid fever (abstract 258). 39th Annual Meeting of the Infectious Diseases Society of America. San Franciso, American Society of Infectious Diseases, 2001, p 83.
24. Doern GV, Brueggemann A, Holley HP, Rauch AM: Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-1213.